Filing Details

Accession Number:
0000899243-22-036010
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-16 16:30:14
Reporting Period:
2022-11-14
Accepted Time:
2022-11-16 16:30:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1840439 Biomea Fusion Inc. BMEA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1856674 J.m. Michael Hitchcock C/O Biomea Fusion, Inc.
900 Middlefield Road, 4Th Floor
Redwood City CA 94063
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-14 5,000 $7.93 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $7.97, inclusive. The reporting person undertakes to provide to Biomea Fusion, Inc., any security holder of Biomea Fusion, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 to this Form 4.